Answers are grounded in this paper and cite their sources.
The safety and quality of blood and blood components are of essential value in transfusion medicine. It is a responsibility of blood establishments to organize their activities so that quality and safety requirements are met. The implementation and maintenance of an effective quality management system (QMS) will greatly contribute to the achievement of this goal. To be fully effective, a QMS should incorporate risk‐based thinking in all aspects of the vein‐to‐vein transfusion process and include quality monitoring, which is carefully planned, continuous and properly evaluated. This study discusses several aspects of quality monitoring and risk management including their role, the importance thereof, objectives and implementation strategies. Quality monitoring is elaborated in detail with regard to quality indicators and quality control of blood components. In addition to describing general aspects of risk management in transfusion medicine, an example of its application is given on labelling of blood and blood components using the format of the EuBIS guide. Considering the biological origin of blood components and specific risks associated with their use, activities of quality monitoring and risk management in transfusion medicine should be strategic and proactive and not reactive.
No takes yet. Share an insight, caveat, or question.
Vuk et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: